YBX1 and medulloblastoma: Canonical pathway analysis of the aforementioned publicly available human medulloblastoma cohort separated by high-low YB-1 expression also identified significant inactivation of the Cholesterol Biosynthesis Pathway (Supplementary Figure S9), highlighting a potentially novel function for YB-1 in the regulation of lipid metabolism in brain tumour cells.